Does Medicare Cover Semaglutide? A Guide for Seniors

It’s one of the most common questions we hear: will Medicare help pay for semaglutide? The honest answer is that it depends on two things — your specific plan, and the medical reason the medication is prescribed.

Medicare Part D covers FDA-approved semaglutide medications for certain medical conditions. It does not cover compounded semaglutide, and it does not cover semaglutide prescribed only for weight loss. Here’s how that breaks down.

What Medicare covers — and what it doesn’t

Coverage hinges on having a qualifying condition, using an FDA-approved product, and meeting your plan’s requirements.

Medicare may cover semaglutide for:

• Type 2 diabetes. Both an injectable and an oral FDA-approved semaglutide are commonly covered under Part D for managing type 2 diabetes, usually with prior authorization. Monthly copays often run from about $40 to $100 depending on your plan’s tier.
• Cardiovascular risk reduction. A separate, higher-dose FDA-approved semaglutide is covered to reduce the risk of heart attack and stroke — but only for people with established cardiovascular disease who also have obesity or are overweight with related conditions. This requires extensive prior-authorization documentation.

Medicare does not cover:

• Semaglutide prescribed for weight loss alone
• Compounded semaglutide from compounding pharmacies
• Off-label uses, such as prediabetes
• Any generic semaglutide (none is FDA-approved at this time)

Federal law specifically excludes medications prescribed primarily for weight loss, even when a physician prescribes them — so without a qualifying condition, you’d pay full retail price, which can run well over a thousand dollars a month.

Your out-of-pocket costs in 2025

There’s real relief built into recent law. Starting in 2025, once your out-of-pocket prescription costs reach $2,000, you pay nothing more for covered medications for the rest of the year. For people taking covered semaglutide, that cap is often reached within the first two to three months.

The Part D stages work like this:

1. Deductible: you pay the full cost until you meet your plan’s deductible.
2. Initial coverage: you pay about 25% of the drug cost.
3. Catastrophic coverage: after $2,000 in out-of-pocket spending, you pay $0 for covered drugs for the remainder of the year.

This is a significant change from previous years, when out-of-pocket costs for expensive medications had no annual ceiling.

Prior authorization: what your doctor documents

Most plans require prior authorization. Knowing what’s needed can speed approval. For a diabetes indication, that typically means recent A1C results, a documented type 2 diabetes diagnosis with the right codes, a list of medications you’ve already tried, and current labs. For the cardiovascular indication, plans generally want records of a prior cardiac event, a current BMI with documentation, and a clear note that the goal is reducing cardiovascular risk — not weight loss.

If a request is denied, you have the right to appeal — and many initial denials come down to incomplete paperwork rather than true ineligibility, so it’s often worth pursuing.

Step therapy and formulary tiers

Many plans use step therapy, meaning you try less-expensive medications first — often metformin, then another oral class — before a GLP-1 medication is approved. Where a medication lands on your plan’s formulary also affects cost: preferred-brand tiers carry lower copays, while non-preferred tiers can mean higher copays or coinsurance.

A word of caution on cheap “semaglutide” deals

There are no FDA-approved generic versions of semaglutide. Compounded versions exist, but they aren’t FDA-approved and aren’t covered by Medicare. Be wary of online ads promising cheap semaglutide — some involve unsafe products or outright scams that target seniors. It’s worth doing your due diligence and working with a licensed provider and pharmacy.

How MDWatch helps seniors

If you qualify for the new Medicare GLP-1 Bridge, brand-name GLP-1s can be covered for about $50/month. And if you don’t qualify — or prefer a cash option — MDWatch offers a medically supervised compounded alternative built for older adults. A few things set it apart:

• Transparent pricing. If you qualify, brand-name GLP-1s can run about $50/month through the Medicare Bridge Program; otherwise our compounded program is about $90 to $140 for a four-week supply — either way, far less than the retail price of brand-name medications, with no hidden fees, insurance hassles, or prior-authorization delays.
• Real medical oversight. A provider reviews your history, starts you at a low dose, and monitors you with regular check-ins and labs — not just a shipped box of medication.
• Care that’s often covered even when the medication isn’t. Medicare frequently helps pay for the visits, coaching, and monitoring around your treatment, even when it doesn’t cover the medication itself.

Whether you qualify for Medicare coverage or need another path, the most important step is knowing your options. Our team can check your specific benefits for free, so you know your exact out-of-pocket cost before you decide anything.